Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Kazuhito Kani"'
Autor:
Shinichiro Shinzaki, Toshimitsu Fujii, Shigeki Bamba, Maiko Ogawa, Taku Kobayashi, Masahide Oshita, Hiroki Tanaka, Keiji Ozeki, Sakuma Takahashi, Hiroki Kitamoto, Kazuhito Kani, Sohachi Nanjo, Takeshi Sugaya, Yuko Sakakibara, Toshihiro Inokuchi, Kazuki Kakimoto, Akihiro Yamada, Hisae Yasuhara, Yoko Yokoyama, Takuya Yoshino, Akira Matsui, Misaki Nakamura, Taku Tomizawa, Ryosuke Sakemi, Noriko Kamata, Toshifumi Hibi
Publikováno v:
Intestinal Research, Vol 16, Iss 4, Pp 609-618 (2018)
Background/Aims The influences of Helicobacter pylori eradication therapy on the disease course of inflammatory bowel disease (IBD) are still unclear. We therefore conducted a multicenter, retrospective cohort study to evaluate the safety of H. pylor
Externí odkaz:
https://doaj.org/article/3e886c3f695e421fb91d56212f82f76d
Autor:
Yusuke Inoue, Shunichi Yanai, Kazutaka Kukita, Yoshihiro Endo, Kazuya Kitamura, Keisuke Kawasaki, Izumi Hasegawa, Motoki Yonekawa, Ken Kawakami, Masaki Katagiri, Hiroki Nakamura, Kazuhito Kani, Takayuki Matsumoto, Shingo Kato, Tomonari Ogawa, Takuya Doi, Kazuhide Higuchi, Kazuki Kakimoto
Publikováno v:
Therapeutic Apheresis and Dialysis
Several adsorptive type devices for ulcerative colitis are used for the induction of remission in patients with active severe disease worldwide. In 2020, the novel apheresis device Immunopure for ulcerative colitis was launched in Japan. Immunopure,
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 117(8)
Transabdominal ultrasound is a promising technique to evaluate inflammatory bowel disease. Several studies have demonstrated a relationship between ultrasound findings and colonic inflammation. However, the applicability of transabdominal ultrasound
Autor:
Taku Kobayashi, Ryosuke Sakemi, Shigeki Bamba, Keiji Ozeki, Taku Tomizawa, Kazuhito Kani, Misaki Nakamura, Toshihiro Inokuchi, Takeshi Sugaya, Yoko Yokoyama, Takuya Yoshino, Masahide Oshita, Toshifumi Hibi, Hisae Yasuhara, Sakuma Takahashi, Kazuki Kakimoto, Noriko Kamata, Akihiro Yamada, Hiroki Kitamoto, Hiroki Tanaka, Yuko Sakakibara, Sohachi Nanjo, Shinichiro Shinzaki, Toshimitsu Fujii, Maiko Ogawa, Akira Matsui
Publikováno v:
Intestinal Research
Background/aims The influences of Helicobacter pylori eradication therapy on the disease course of inflammatory bowel disease (IBD) are still unclear. We therefore conducted a multicenter, retrospective cohort study to evaluate the safety of H. pylor
Publikováno v:
Digestion. 97:59-63
Background: Ulcerative proctitis, one of the disease types of ulcerative colitis, is considered one of the initial manifestations of ulcerative colitis. Prevention of aggravation of ulcerative proctitis is important for improving the prognosis of ulc
Publikováno v:
Journal of Crohn's and Colitis. 14:S374-S375
Background Anti-TNF α antibodies have contributed to the good prognosis in patients with inflammatory bowel diseases (IBDs). Adherence of these drugs affects the treatment effects in patients with IBDs. Recently, the use of an adalimumab (ADA) autoi
Publikováno v:
Journal of Crohn'scolitis. 12(suppl_1)
BACKGROUND Oral mesalazine effectively induces and maintains remission in inflammatory bowel diseases (IBD) patients. However, adherence to the drug regimen is low. Shared decision-making (SDM) is considered effective in promoting treatment adherence
Publikováno v:
Journal of Crohn's and Colitis. 15:S543-S543
Background Ustekinumab, anti-IL12/23 antibody have contributed to the good prognosis in patients with Crohn’s disease (CD). However, good biomarkers for the prediction of treatment- effects of ustekinumab (UST) are not clear. We elucidated whether
Autor:
Shingo, Kato, Akira, Ishibashi, Kaori, Sugiura, Kazuhito, Kani, Tomonari, Ogawa, Hajime, Hasegawa, Koji, Yakabi
Publikováno v:
Contributions to nephrology. 196
Idiopathic acute-on-chronic inflammation in the gastrointestinal tract is an etiology of inflammatory bowel disease (IBD). Granulocyte and monocyte adsorptive apheresis (GMA) is a nonpharmacological treatment tool for patients with IBD. Here, we pres
Autor:
Hajime Hasegawa, Kazuhito Kani, Shingo Kato, Kaori Sugiura, Tomonari Ogawa, A Ishibashi, Koji Yakabi
Background Idiopathic acute-on-chronic inflammation in the gastrointestinal tract is an etiology of inflammatory bowel disease (IBD). Granulocyte and monocyte adsorptive apheresis (GMA) is a nonpharmacological treatment tool for patients with IBD. He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69cacfacd8cf8c0344f145d2104ae923
https://doi.org/10.1159/000485723
https://doi.org/10.1159/000485723